Differences between hospitals in attainment of parathyroid hormone treatment targets in chronic kidney disease do not reflect differences in quality of care

by Peeters Mieke J, van Zuilen Arjan D, AJG van den Brand Jan, Blankestijn Peter J, AGJ ten Dam Marc, FM Wetzels Jack
Published 2012-08-01

Fibroblast growth factor 23 is associated with proteinuria and smoking in chronic kidney disease: An analysis of the MASTERPLAN cohort

by Vervloet Marc G, van Zuilen Arjan D, Heijboer Annemieke C, ter Wee Piet M, Bots Michiel L, Blankestijn Peter J, Wetzels Jack FM
Published 2012-04-01

Multifactorial approach and superior treatment efficacy in renal patients with the aid of nurse practitioners. Design of The MASTERPLAN Study [ISRCTN73187232]

by Vervoort Gerald, van de Ven Peter JG, Kaasjager Karin AH, ten Dam Marc AGJ, van Buren Marjolijn, Bots Michiel L, Blankestijn Peter J, van der Tweel Ingeborgh, van Zuilen Arjan D, Vleming Louis-Jean, Ligtenberg Gerry, Wetzels Jack FM
Published 2006-03-01